A Study Into the Use of and Need for Healthcare Services, for HIV Infected People, from Diagnosis Until Death

Total Page:16

File Type:pdf, Size:1020Kb

A Study Into the Use of and Need for Healthcare Services, for HIV Infected People, from Diagnosis Until Death University of Wollongong Thesis Collections University of Wollongong Thesis Collection University of Wollongong Year 1995 A study into the use of and need for healthcare services, for HIV infected people, from diagnosis until death Margaret I. Jamieson University of Wollongong Jamieson, Margaret I., A study into the use of and need for healthcare services, for HIV infected people, from diagnosis until death, Doctor of Philosophy thesis, Department of Public Health and Nutrition, University of Wollongong, 1995. http://ro.uow.edu.au/theses/1701 This paper is posted at Research Online. A study into the use of and need for healthcare services, for HIV infected people, from diagnosis until death. A thesis presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy. from University of Wollongong by Margaret I. Jamieson. BA(Glas.C.T) MPH (Dundee). Department of Public Health and Nutrition. 1995. 11 I hereby declare that I am the sole author of this thesis. This thesis does not incorporate without ackowledgement any material previously pubUshed or written by another person except where due reference is made in the text. Margaret I Jamieson. Ill ABSTRACT The aim of this study was to determine the use of the healthcare system by people with HIV /AIDS, and to identify and compare variations in service provision to patients with similar needs, and variations between needs and service provision. The variations would suggest changes in service management in the interests of improvements in cost /effectiveness. Central to health service management is the need for information. The primary hypothesis of this study is that information systems need to be refined to support management of AIDS/HIV as a chronic, infectious condition, from initial manifestation through to death. It is hypothesized that it is impractical to manage healthcare deUvery without recognition of the disease processes and changes in social factors over the duration of the disease; or without taking account of the hnks between episodes of care, and the extent of care management and access. This was a longitudinal study, which involved two hundred and ninety—two HIV infected respondents. Respondents entered the study through networking, all volunteered. The study duration was from March 1993 until March 1994. In addition to these recipients of care, interviews were undertaken with service providers. This information was used to corroborate the findings of those persons who were HIV infected. Although limited by issues such as volunteer bias, small numbers and an inability to access clinical records, the study produced much useful information. It was possible to ascertain health service utilization for a group of individuals who exhibited a wide range of symptoms. The study also demonstrated the difficulties of accessing a heavily researched group and in maintaining contact over a long period of time. The patient population was highly mobile IV in seeking and accessing healthcare. This mobility is reflective of the problems of confidentiality, unmet need within an area and patient choice. The main findings of the study demonstrated that people sought healthcare from a wide variety of sources. There was considerable use of voluntary and statutory services. Service utilization was influenced by specific demographic features such as living alone, being a professional and using a private physician and/or general practitioner as their main source of care. A series of ten levels of HIV infection, from diagnosis through to death, were identified. The levels indicate increasing disease severity and increasing healthcare needs. One trend from this study suggests that the bulk of care is happening in the community with a heavy involvement of voluntary carers. The involvement of a significant number of agencies in the delivery of care impacts upon costs and co­ ordination of care. There are substantial costs involved including personal costs that were beyond the scope of this study to evaluate. Whilst the use of Diagnosis Related Groups is applicable to the estimation of hospital costs, given the trend towards community care, it is important to develop a series of cost measures that incorporate community as well as hospital costs. The findings of the study suggest that there is an urgent need to develop a stmctured approach to co-ordination of care. A development of a series of cost measures that incorporate community and hospital cost is required. Whilst there is no such thing as a typical patient, it is possible to identify a series of phases of HIV infection with levels of severity. Each stage indicates a differing need for and use of healthcare services. The importance of collecting demographic data was reinforced. It was possible to show that for this group of HIV infected people, certain factors, were implicated in the frequency and use of healthcare services. The need for additional services was brought to the fore, particularly services relating to specialized home care and community psychiatric support Acknowledgments. First and foremost, I wish to acknowledge with gratitude, the assistance of Professor Don Hindle, who supervised and encouraged me in my endeavors. Secondly, Dr Lindsey Harrison deserves special mention, her keen supervision in the later stages of this project, encouragement, unwavering support and guidance were without equal. Professor R Harris deserves a mention for his patient guidance and asssistance with the final stages of this thesis. To the participants who volunteered in this study goes my deep gratitude and thanks. I hope I have clearly and fairly represented their views in this thesis. I especially thank Bob—whizzing around Sydney on his Harley Davidson was one of the tmly memorable moments of my time in Australia.(I'm still of the opinion that I could have driven it!). To Gillian Spooner for her patience in allowing me access to the whizz-bang technology and her patience with my ineptitude. On both sides of the world, I have received a great deal of personal support from friends and family, without whom, this thesis would not have been completed. In particular, I would hke to acknowledge the friendship and help of: Ty Francis, Barbara Pyne (for endless coffees, chats and sound support), Barbara Meyer (for reassurance that everyone goes through these phases!) Atmn, Sylvia and Ingrid for just being them!! Lesley for letters from Minsk—there is another Hfe out there and finally, Mil for love, support and letting me be a kept woman and my folks for always being there for me. I hope the writing of this thesis has not strained the boundaries of family and friendship ties too much. VI To all who have been party to this thesis, directiy or indirectly, goes my sincere thanks. Their contributions to this piece of work are acknowledged, while any mistakes lying herein must remain my own. This thesis was completed with the funding assistance of a University of Wollongong Post-Graduate Award (April 1994-1995). Vll Table of Contents Title page i Statement of Authorship i i Abstract iii Acknowledgements v Table of Contents vii List of Tables x List of Figures xii Chapter 1 Introduction 1 1.2 Origins of the research 4 1.3 Study Objectives 6 1.4 Formal statement of the research hypotheses 7 1.5 Thesis Stmcture 8 Chapter 2 The Nature of AIDS / HIV Infection. Overview 11 2.1 The Nature of AIDS / HIV Infection 14 2.2 Transmission of the Virus 17 2.3 Disease Progression 24 Vlll 2.3 Global Patterns of the HIV Epidemic 26 2.4 Infection in Australia 28 2.5 Clinical Management 32 2.5.1 The Range of HIV Infection 32 2.5.2.Management of HIV Infection 37 2.6 Case Management 40 2.7 Conclusion 45 Chapter 3 Social perceptions of AIDS and the subsequent impact on policy development. Overview 47 3.1 The Perceptions of AIDS and the resultant impact on Health Services 50 3.2 The Plague of the Twentieth Century ? 52 3.3 AIDS as a Chronic Disease 60 3.4 AIDS as aChronic Infectious Pandemic 64 3.5 Response of the Health-care Services 67 3 6 Current Service Responses in AustraUa 72 3.7 Australian Federal Response to AIDS/HFV 74 3.8 Health Service Response in New South Wales 77 3.9 Conclusion 80 Chapter 4 Health Service Access, Use and Costs. Overview 82 4.1 Access to services 85 4.2 UtiUsation of Health Care Services 92 4.3 The Costs of AIDS/HIV 98 4.3.2 Case-mix and Diagnosis Related Groups 99 4.3.3 Costing Studies 104 4.4 The Impact on the HIV Infected Individual 109 IX 4.5 Conclusion 112 Chapter 5 Method Overview 114 5.1 Design Issues 117 5.1.1 The measurement of need, cost and the utilisation of healthcare as a basis for service planning 117 5.1.2 Research context 119 5.13. Research Participation 120 5.1 4.Data Capture 124 5.1.5 Confidentiality 131 5.5 Study Method 136 5.3.1 The recipients of healthcare-People with HIV/AIDS 137 5.3.2 Health Care Providers 138 5.4 The data collection instruments and their constraction 139 5.4.1 The CUent Questionnaire 139 5.4.2 The Interview Schedule 142 5.5 Method of analysis 143 5.6 Conclusion 145 Chapter 6 The Pilot Study Overview 147 6 1 Study Design 149 6.2 The Interviews of Service Providers 149 6.2 (a) Data Collection: the Interview Schedule 149 6.2 (b) The Sample 150 6.2 (c)Metiiod of data capture 150 6.3 Data Analysis of the Interviews 150 6.4 Interview Findings 151 6.5 Self -Enumeration Questionnaire for ADDS/HIV Patients 163 6.6 Results 165 6.6.2 Clinical Characteristics of the Sample 169 6.6.2(a) The Results from the Mental Health Questionnaire 169 6.7 Discussion 188 6.8 Conclusion 193 Chapter 7:Results Overview 194 Part l:The Interviews of Service Providers 197 7:2 (a) The interview schedule:data collection 197 7:2(b) The Sample 197 7:2 (c)Method of data capture 198 7:3 Data Analysis of the Interviews 199 7:4 Interview Findings 200 7 Part 2:The results of the self-enumeration questionnaire 221 Chapter 8:Discussion and Conclusions 8.1 Discussion of the results of the study 252 8.2 Limitations of Study 266 8.3 Areas for future research 272 8.4 Conclusions 273 References 277 Appendices.
Recommended publications
  • Qualitative Study to Explore the Knowledge and Attitude of Pregnant Women Regarding HIV/AIDS Testing in Kotayk Region and in Yerevan, Armenia
    Qualitative study to explore the knowledge and attitude of pregnant women regarding HIV/AIDS testing in Kotayk region and in Yerevan, Armenia Utilizing Professional Publication Framework Henrik Khachatryan, MD, MPH candidate, American University of Armenia Primary Adviser: M. Thompson, MS, DrPH Secondary Adviser: K. White, RN, PhD, CNAA October 2005 Table of Contents INTRODUCTION ...........................................................................................................................................................1 Background Information and Literature review....................................................................................................1 Rationale for the Research and Research Questions.............................................................................................4 METHODS AND MATERIALS........................................................................................................................................5 Study design...........................................................................................................................................................5 Study population ....................................................................................................................................................5 Sampling and Study Setting...................................................................................................................................6 Data collection Instrument.....................................................................................................................................6
    [Show full text]
  • Partners with Mixed HIV Status
    Partners With Mixed HIV Status SERODISCORDANT RELATIONSHIPS Relationships in which one or more people has HIV and one or more people do not have HIV are sometimes called serodiscordant or mixed serostatus. The term serodiscordant is made up of two roots: 1. Sero—meaning blood 2. Discordant—meaning different or non-matching HIV isn’t the first topic that comes up when most people start dating. You may not know the HIV status of your partner(s). You might not even have been tested yourself. It can be very difficult to talk about HIV status. WHAT ARE THE SPECIAL ISSUES FOR SERODISCORDANT RELATIONSHIPS? People in mixed HIV status relationships face all the same things as other people in relationship. But there are some extra issues: The partner(s) with HIV might focus on not infecting their partner(s). The partner(s) who do not have HIV may concentrate on taking care of the person/people with HIV. This can cause a serious lack of balance in the relationship. HIV can cause changes in the body. Antiretroviral medications (ARVs) may have unpleasant side effects. This might give the partner(s) with HIV negative feelings about their body and their health. It may be difficult to feel attractive and have a normal romantic relationship. Fear of transmitting HIV can cause an excess of caution. This might even stop all sexual activity. Review the following fact sheets for more information: Stopping the Spread of HIV Safer Sex Guidelines Condoms Ways HIV is Transmitted Try to have open discussions about your desires, your fears, and your limits.
    [Show full text]
  • Sexually Transmitted Diseases Treatment Guidelines, 2015
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory
    [Show full text]
  • This Project Has Been Supported with Unrestriced Grants from Abbvie Gilead Sciences HEXAL Janssen-Cilag MSD Viiv Healthcare By
    This project has been supported with unrestriced grants from AbbVie Gilead Sciences HEXAL Janssen-Cilag MSD ViiV Healthcare By Marcus Altfeld, Hamburg/Boston (USA) Achim Barmeyer, Dortmund Georg Behrens, Hannover Dirk Berzow, Hamburg Christoph Boesecke, Bonn Patrick Braun, Aachen Thomas Buhk, Hamburg Rob Camp, Barcelona (Spain/USA) Rika Draenert, Munich Christian Eggers, Linz (Austria) Stefan Esser, Essen Gerd Fätkenheuer, Cologne Gunar Günther, Windhoek (Namibia) Thomas Harrer, Erlangen Christian Herzmann, Borstel Christian Hoffmann, Hamburg Heinz-August Horst, Kiel Martin Hower, Dortmund Christoph Lange, Borstel Thore Lorenzen, Hamburg Tim Niehues, Krefeld Christian Noah, Hamburg Ramona Pauli, Munich Ansgar Rieke, Koblenz Jürgen Kurt Rockstroh, Bonn Thorsten Rosenkranz, Hamburg Bernhard Schaaf, Dortmund Ulrike Sonnenberg-Schwan, Munich Christoph D. Spinner, Munich Thomas Splettstoesser (Figures), Berlin Matthias Stoll, Hannover Hendrik Streeck, Essen/Boston (USA) Jan Thoden, Freiburg Markus Unnewehr, Dortmund Mechthild Vocks-Hauck, Berlin Jan-Christian Wasmuth, Bonn Michael Weigel, Schweinfurt Thomas Weitzel, Santiago (Chile) Eva Wolf, Munich HIV 2015/16 www.hivbook.com Edited by Christian Hoffmann and Jürgen K. Rockstroh Medizin Fokus Verlag IV Christian Hoffmann, M.D., Ph.D. ICH Stadtmitte (Infektionsmedizinisches Centrum Hamburg) Glockengiesserwall 1 20095 Hamburg, Germany Phone: + 49 40 2800 4200 Fax: + 49 40 2800 42020 [email protected] Jürgen K. Rockstroh, M.D., Ph.D. Department of Medicine I University of Bonn Sigmund-Freud-Strasse 25 53105 Bonn, Germany Phone: + 49 228 287 6558 Fax: + 49 228 287 5034 [email protected] HIV Medicine is an ever-changing field. The editors and authors of HIV 2015/16 have made every effort to provide information that is accurate and complete as of the date of publication.
    [Show full text]
  • Use of Withdrawal (Coitus Interruptus) for Both Pregnancy and HIV Prevention Among Young Adults in Rakai, Uganda
    2421 Use of Withdrawal (Coitus Interruptus) for Both Pregnancy and HIV Prevention among Young Adults in Rakai, Uganda Jenny A. Higgins, PhD, MPH,* Laura Gregor, BS,* Sanyukta Mathur, DrPH, MS,† Neema Nakyanjo, MS,‡ Fred Nalugoda, MHS,‡ and John S. Santelli, MD, MPH† *University of Wisconsin, Madison, WI, USA; †Columbia University, New York, NY, USA; ‡Rakai Health Sciences Program, Kalisizo, Rakai District, Uganda DOI: 10.1111/jsm.12375 ABSTRACT Introduction. Although understudied in the context of AIDS, use of withdrawal (coitus interruptus) with or in place of other prevention methods affects exposure to both pregnancy and human immunodeficiency virus (HIV). Aim. We used mixed methods to assess use of withdrawal among 15–24-year-olds in a rural Ugandan setting with considerable HIV prevalence. Methods. We measured withdrawal reporting among (i) sexually active 15–24-year-olds enrolled in a quantitative community survey (n = 6,722) and (ii) in-depth qualitative interview participants systematically selected from the latest round of the community survey (N = 60). Respondents were asked about family planning and HIV prevention practices, including a direct question about withdrawal in the in-depth interviews. Main Outcome Measures. The main outcome measures were reports of current use of withdrawal on the quanti- tative survey (general question about family planning methods) and reports of current or recent use withdrawal in qualitative interviews (specific question about withdrawal). Qualitative interviews also probed for factors associated with withdrawal use. Results. Although less than 1% of quantitative survey participants spontaneously named withdrawal as their current family planning method, 48% of qualitative interview respondents reported current or lifetime use of withdrawal.
    [Show full text]
  • HIV and Pregnancy: a Short Review Sofoudis C* 2Nd Department of Obstetrics and Gynecology University of Athens, Aretaieion Hospital, Greece
    ical C lin as C e f R o l e Sofoudis, J Clin Case Rep 2014, 4:10 a p n o r r DOI: 10.4172/2165-7920.1000436 t u s o J Journal of Clinical Case Reports ISSN: 2165-7920 Case Report Open Access HIV and Pregnancy: A Short Review Sofoudis C* 2nd Department of Obstetrics and Gynecology University of Athens, Aretaieion Hospital, Greece Abstract The incidence and existence of human immunodeficiency virus concerning women of reproductive age continues to increase globally. The care of HIV-infected women is not simple and must be focused on including the current and future health of these women, the minimization of the risk of maternal–infant transmission and the maintenance of the well-being of the fetus and neonate. Many maternal and obstetrical factors can affect the vertical transmission. The answer to this problem is the optimal medical and obstetrical care. Keywords: Pregnancy; HIV; Vertical transmission of the correlation between its presence and the immunsupression [12,13]. There are many pathological connections which can clear Introduction out this correlation. To begin with, we must give a great attention to The human immunodeficiency virus continues to be expanded the compromised immune status and general poor health of HIV- around the world causing an estimated 16,000 new infections per day infected women which allow them to become more vulnerable to [1]. 2.1 million women and 590,000 children below age of 15 were infections and mostly to puerperal sepsis [14]. Additionally, HIV newly infected through their mothers before or during birth or through related thrombocytopenia may lead to increased risk of hemorrhage.
    [Show full text]
  • FAQ113 -- HIV and Pregnancy
    AQ The American College of Obstetricians and Gynecologists FREQUENTLY ASKED QUESTIONS FAQ113 fPREGNANCY HIV and Pregnancy • What is human immunodeficiency virus (HIV)? • How do you get HIV? • How do you get AIDS? • How long does it take for HIV to develop into AIDS? • Can HIV be treated? • If I am infected with HIV and pregnant, can I pass HIV to my baby? • What can I do to reduce the risk of passing HIV on to my baby? • Why is HIV treatment recommended during pregnancy? • Are there any side effects of HIV drugs? • What is my viral load? • Why is it important for my viral load and CD4 cell count to be monitored? • Should I still use condoms during sex even though I am pregnant? • Are there extra risks for me if I am HIV positive and I have a cesarean delivery? • After I give birth, how will I know if my baby is infected with HIV? • Glossary What is human immunodeficiency virus (HIV)? Human immunodeficiency virus (HIV) is the virus that causes acquired immunodeficiency syndrome (AIDS). How do you get HIV? HIV enters the bloodstream by way of body fluids, such as blood or semen. Once in the blood, the virus invades and kills CD4 cells. CD4 cells are key cells of the immune system. When these cells are destroyed, the body is less able to fight disease. How do you get AIDS? AIDS occurs when the number of CD4 cells decreases below a certain level and the person gets sick with diseases that the immune system would normally fight off.
    [Show full text]
  • British HIV Association Guidelines for the Management of HIV in Pregnancy and Postpartum 2018 (2019 Second Interim Update)
    British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018 (2019 second interim update) BHIVA guidelines on the management of HIV in pregnancy and postpartum Guideline writing group Dr Yvonne Gilleece (Chair) Honorary Clinical Senior Lecturer and Consultant Physician in HIV and Genitourinary Medicine, Brighton and Sussex University Hospitals NHS Trust Dr Shema Tariq Postdoctoral Clinical Research Fellow, University College London, and Honorary Consultant Physician in HIV, Central and North (Vice-chair) West London NHS Foundation Trust Ms Funmi Awosusi Barts Health NHS Trust, London/HIV Pharmacy Association Dr Alasdair Bamford Consultant in Paediatric Infectious Diseases, Great Ormond Street Hospital for Children NHS Foundation Trust, London Dr Sanjay Bhagani Consultant Physician in Infectious Diseases, Royal Free Hospital NHS Trust, London Dr Laura Byrne Locum Consultant in HIV Medicine, St George’s University Hospitals NHS Foundation Trust, London Dr Emily Clarke Consultant in Genitourinary Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust Ms Polly Clayden UK Community Advisory Board representative/HIV treatment advocates network Dr Hermione Lyall Clinical Director for Children’s Services and Consultant Paediatrician in Infectious Diseases, Imperial College Healthcare NHS Trust, London Dr Rebecca Metcalfe Consultant in Sexual Health and HIV Medicine, NHS Greater Glasgow and Clyde Dr Adrian Palfreeman Consultant in Genitourinary Medicine, University Hospitals of Leicester NHS Trust
    [Show full text]
  • HIV During Pregnancy, Labor and Delivery, and After Birth
    A Service of the U.S. Department of Health and Human Services HIV During Pregnancy, Labor and Delivery, and After Birth Health Information for HIV Positive Pregnant Women January 2006 Fact Sheets P.O. Box 6303, Rockville, MD 20849-6303 Telephone: 1-800-448-0440 International: 301-519-0459 Fax: 301-519-6616 TTY/TTD: 888-480-3739 Live Help: http://aidsinfo.nih.gov/LiveHelp E-mail: [email protected] Web: http://aidsinfo.nih.gov A Service of the U.S. Department of Health and Human Services HIV During Pregnancy, Labor and Delivery, and After Birth This series of fact sheets is intended for women who are HIV positive and pregnant or have recently given birth. These fact sheets describe the steps an HIV positive pregnant woman can take to preserve her health and prevent transmission of HIV to her baby. These fact sheets are designed as a series but can also be used as stand-alone documents. The information in these fact sheets is based on the U.S. Public Health Service's Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States and Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (available at http://aidsinfo.nih.gov/guidelines). Table of Contents HIV Testing and Pregnancy Drug Regimens for HIV Positive Pregnant Women Safety and Toxicity of Anti-HIV Medications During Pregnancy Delivery Options for HIV Positive Pregnant Women HIV Positive Women and Their Babies After Birth This information is based on the U.S.
    [Show full text]
  • Microcosm: a Model of Social and Structural Drivers of HIV and Interventions to Reduce HIV Incidence in High-Risk Populations in South Africa
    bioRxiv preprint doi: https://doi.org/10.1101/310763; this version posted April 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. MicroCOSM: a model of social and structural drivers of HIV and interventions to reduce HIV incidence in high-risk populations in South Africa Centre for Infectious Disease Epidemiology and Research working paper April 2018 Leigh F. Johnson, Mmamapudi Kubjane, Haroon Moolla Centre for Infectious Disease Epidemiology and Research Correspondence to: Dr Leigh Johnson Centre for Infectious Disease Epidemiology and Research University of Cape Town Anzio Road Observatory 7925 South Africa Tel: +27 21 406 6981 Fax: +27 21 406 6764 Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/310763; this version posted April 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Executive summary Background and objectives South Africa has one of the highest HIV incidence rates in the world. Although much research has focused on developing biomedical strategies to reduce HIV incidence, there has been less investment in prevention strategies that address the social drivers of HIV spread. Understanding the social determinants of HIV is closely related to understanding high-risk populations (‘key populations’), since many of the factors that place these key populations at high HIV risk are social and behavioural rather than biological.
    [Show full text]
  • Hoffmann Rockstroh |
    Hoffmann| Rockstroh HIV 2015/2016 www.hivbook.com Medizin Fokus Verlag This project has been supported with unrestriced grants from AbbVie Gilead Sciences HEXAL Janssen-Cilag MSD ViiV Healthcare By Marcus Altfeld, Hamburg/Boston (USA) Achim Barmeyer, Dortmund Georg Behrens, Hannover Dirk Berzow, Hamburg Christoph Boesecke, Bonn Patrick Braun, Aachen Thomas Buhk, Hamburg Rob Camp, Barcelona (Spain/USA) Rika Draenert, Munich Christian Eggers, Linz (Austria) Stefan Esser, Essen Gerd Fätkenheuer, Cologne Gunar Günther, Windhoek (Namibia) Thomas Harrer, Erlangen Christian Herzmann, Borstel Christian Hoffmann, Hamburg Heinz-August Horst, Kiel Martin Hower, Dortmund Christoph Lange, Borstel Thore Lorenzen, Hamburg Tim Niehues, Krefeld Christian Noah, Hamburg Ramona Pauli, Munich Ansgar Rieke, Koblenz Jürgen Kurt Rockstroh, Bonn Thorsten Rosenkranz, Hamburg Bernhard Schaaf, Dortmund Ulrike Sonnenberg-Schwan, Munich Christoph D. Spinner, Munich Thomas Splettstoesser (Figures), Berlin Matthias Stoll, Hannover Hendrik Streeck, Essen/Boston (USA) Jan Thoden, Freiburg Markus Unnewehr, Dortmund Mechthild Vocks-Hauck, Berlin Jan-Christian Wasmuth, Bonn Michael Weigel, Schweinfurt Thomas Weitzel, Santiago (Chile) Eva Wolf, Munich HIV 2015/16 www.hivbook.com Edited by Christian Hoffmann and Jürgen K. Rockstroh Medizin Fokus Verlag IV Christian Hoffmann, M.D., Ph.D. ICH Stadtmitte (Infektionsmedizinisches Centrum Hamburg) Glockengiesserwall 1 20095 Hamburg, Germany Phone: + 49 40 2800 4200 Fax: + 49 40 2800 42020 [email protected] Jürgen K. Rockstroh, M.D., Ph.D. Department of Medicine I University of Bonn Sigmund-Freud-Strasse 25 53105 Bonn, Germany Phone: + 49 228 287 6558 Fax: + 49 228 287 5034 [email protected] HIV Medicine is an ever-changing field. The editors and authors of HIV 2015/16 have made every effort to provide information that is accurate and complete as of the date of publication.
    [Show full text]
  • Hiv in Pregnancy
    WHO/RHT/98.24 UNAIDS/98.44 Distr.: General HIV IN PREGNANCY: A REVIEW ACKNOWLEDGEMENTS This paper was prepared by James McIntyre, Perinatal HIV Research Unit, Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa. A working group on HIV in pregnancy, composed of staff from WHO’s Reproductive Health Programme and UNAIDS, oversaw this work and the subsequent review of the paper. © World Health Organization, 1998 © Joint United Nations Programme on HIV/AIDS (UNAIDS), 1998 This document is not a formal publication of the World Health Organization (WHO) and UNAIDS, but all rights are reserved by these agencies. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. For authorization to translate the work in full, and for any use by commercial entities, application and enquiries should be addressed to Department of Reproductive Health, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and the reprint and translations that are already available. The designations employed and the presentation of the material in this work does not imply the expression of any opinion whatsoever on the part of WHO and UNAIDS concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers and boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]